SYNOVIAL SARCOMAS
Clinical trials for SYNOVIAL SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMAS trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy targets rare sarcoma in Late-Stage trial
Disease control Recruiting nowThis study tests a new treatment called TBI-1301 for people with a rare type of cancer called synovial sarcoma that has spread or come back. The treatment uses the patient's own immune cells, modified to attack cancer cells with a specific marker (NY-ESO-1). About 5 adults with a…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE3 • Sponsor: Takara Bio Inc. • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
Proton beams take aim at inoperable sarcomas in new norwegian trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. The main goal is to see if the t…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
New study aims to cut radiation side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether giving a shorter course of radiation (3 weeks instead of longer) before surgery for soft tissue sarcoma can reduce long-term side effects. Each patient's treatment is personalized by choosing between proton or standard X-ray radiation. The study will enro…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for tough cancers: first human trial of AOH1996 begins
Disease control Recruiting nowThis study is for people with solid tumors (like lung, ovarian, or pancreatic cancer) that have stopped responding to standard treatments. It tests a new drug called AOH1996, which works by blocking certain enzymes that cancer cells need to grow. The main goals are to find the be…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Promising combo therapy for childhood cancers enters human trials
Disease control Recruiting nowThis study tests a combination of two drugs—Lutathera (a targeted radiation therapy) and olaparib (a PARP inhibitor)—in children and teens aged 3 to 18 with solid tumors that have come back or not responded to standard treatment. The goal is to find the safest dose and see if the…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated May 18, 2026 12:00 UTC